The 48th edition of the most important conference dedicated to TB epidemic was held in Mexico on 11 to 14 October 2017. The Union president joined INCURE side session!
Delegates from more than 100 countries, among which healthcare specialists, researchers, global advocates and scientists have united their efforts to take another step on the way to TB epidemic elimination. The moto of this year’s conference was ‘Accelerating Toward Elimination’.
The main highlights were preliminary results from Stage 1 of the STREAM randomized clinical trial that demonstrated that the nine-month treatment regimen being tested for multidrug-resistant tuberculosis achieved favorable outcomes and is very close to the effectiveness of the 20-24 month regimen, when both regimens are given under trial conditions. New Wireless Observed Therapy was presented as a new way fo TB treatment adherence. And the new Zoonotic TB Roadmap was launched to prevent animal to human transmission.
INCURE presented own stand and took part in one of the satellite sessions- ‘Severe TB and other risk factors of TB mortality: is there a challenge to detect and prevent?’
High level scientists and researchers presented their works in following reports:
Rovina Ruslami with ‘Intensive antibiotics treatment to improve outcomes in TB meningitis’.
Low concentration of isoniazid and rifampicin in serum as the reason for poor treatment results in TB patients (Yurii Feschenko, T.Tlustova, Ukraine)
Importance of intravenous chemotherapy of TB at the present stage (Vladimir Krasnov, Russian Federation)
Efficacy and total costs of intravenous administration of anti-tuberculosis drugs in patients with multidrug-resistant tuberculosis (Nataliia Lytvynenko, Ukraine)
The Union president Jeremiah Chakaya Muhwa showed high interest to the topic and participated with his own report- ‘Severe TB: death rate and the main reasons’ adding that guidelines for TB treatment often neglect severely ill patients and their needs. The problem has to be solved in the nearest future in order to improve the outcomes of the treatment.
01/11/2017
